Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
Japanese Heart Journal|November 1, 1983
Studies on concurrent alpha- and beta-adrenoceptor blocking action of S-596 (arotinolol)N Takekoshi, E Murakami, S Matsui, et al.American Heart Journal|April 1, 1995
Assessment of working skeletal muscle oxygenation in patients with chronic heart failureS Matsui, N Tamura, T Hirakawa, et al.Japanese Circulation Journal|August 1, 1991
Disappearance of mitral valve regurgitation after successful percutaneous transluminal coronary angioplastyY H Cahyadi, E Murakami, N Takekoshi, et al.Clinical Cardiology|June 1, 1994
Urinary carnitine excretion in patients with heart failureS Matsui, T Sugita, M Matoba, et al.Nihon Naibunpi Gakkai Zasshi|March 20, 1988
[A case of chemical hyperthyroidism induced by antiarrhythmic agent amiodarone]E Miyauchi, K Uchida, I Yamamoto, et al.Autoimmunity|January 1, 1995
Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptorsS Matsui, M L Fu, M Shimizu, et al.The Journal of Cardiovascular Surgery|May 1, 1986
A comparison of the results of A-C bypass grafting in collateral and non-collateral groupsT Shimizu, M Nakajima, K Shimazu, et al.Japanese Circulation Journal|March 1, 1989
Body surface potential mapping in anterior myocardial infarction--a longitudinal study in acute, convalescent and chronic phasesY H Cahyadi, E Murakami, N Takekoshi, et al.Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|May 5, 1999
Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?S Kanemitsu, N Takekoshi, S Matsui, et al.Japanese Circulation Journal|December 1, 1979
Hemodynamic effects of sublingual nifedipine in congestive heart failureS Matsui, E Murakami, N Takekoshi, et al.Pageof 18